Emergent BioSolutions Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 11/11/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.7 | $1.0 | $1.0 | $1.1 | — |
| Operating income | $0.1 | -$0.1 | -$0.7 | -$0.2 | — |
| Net income | $0.1 | -$0.2 | -$0.8 | -$0.2 | — |
| Cash Flow Statement | |||||
| Free cash flow | $0.2 | $<0.1 | -$0.3 | -$0.1 | — |
| Share repurchases | $<0.1 | $0.0 | $0.0 | $0.1 | $0.2 |
Shares outstanding 51.6M · Free float 12.3%
Annual filing data through FY ended December 31, 2025; float as of August 26, 2026.